諾獎(jiǎng)委因授獎(jiǎng)國際干細(xì)胞研究協(xié)會(huì)（ISSCR）騙子而遭起訴

    我們要把“首起起訴諾獎(jiǎng)委誹謗和不公平競爭案”刊登在《再生醫(yī)學(xué)之聲》上。國際干細(xì)胞研究協(xié)會(huì)（ISSCR）的山中伸彌把4種致癌基因放入實(shí)驗(yàn)老鼠的皮膚細(xì)胞中，然后就聲稱自己已經(jīng)生成了人類全能胚胎干細(xì)胞（(hESCs)的安全的成體細(xì)胞替代物；并在沒有任何真正干細(xì)胞意義上的實(shí)現(xiàn)干細(xì)胞長期穩(wěn)定自我更新的科學(xué)證據(jù)的情況下把該替代物稱為誘導(dǎo)多能干細(xì)胞（iPS細(xì)胞）。
    山中伸彌的誘導(dǎo)多能干細(xì)胞，確切地說，應(yīng)該是誘導(dǎo)多能體細(xì)胞或人工改組成體細(xì)胞。雖然科學(xué)術(shù)語要求要盡可能準(zhǔn)確，但山中伸彌的誘導(dǎo)多能干細(xì)胞也未免太含糊不清、偏離事實(shí)了。之前所有和山中伸彌做過同樣研究的人（不在少數(shù)）都具有科學(xué)誠信，稱他們自己的研究為癌癥研究。唯一不同的是山中伸彌的研究發(fā)表在了享有聲望的頂尖科學(xué)雜志《細(xì)胞》上（如何發(fā)表的呢？），并很快得到了響應(yīng)，其中包括ISSCR中一些著名科學(xué)家如干細(xì)胞之父Jamie Thomson、哈佛的Rudy Jaenisch和George Daley，甚至還有一個(gè)大牌科學(xué)家委員會(huì)竟懷揣光鮮的政治利益或目的為他競選諾貝爾獎(jiǎng)。由國際干細(xì)胞研究協(xié)會(huì)的山中伸彌生成的iPS異常細(xì)胞是一場嚴(yán)重的干細(xì)胞騙局，是喪失了科學(xué)誠信之人所制造的騙局，誤導(dǎo)干細(xì)胞領(lǐng)域和公眾造成公共和納稅人的巨大浪費(fèi)。由國際干細(xì)胞研究協(xié)會(huì)的山中伸彌生成的iPS異常細(xì)胞已經(jīng)對(duì)正常干細(xì)胞研究構(gòu)成了不公平競爭，阻礙了人類胚胎干細(xì)胞研究的發(fā)展。具體可參見我們的博客：“加州再生醫(yī)學(xué)研究所（CIRM）挪用加州資金資源用于誘導(dǎo)成體干細(xì)胞騙局研究（加州再生醫(yī)學(xué)研究所iPS細(xì)胞協(xié)會(huì)）違反71號(hào)提案：厚臉皮的ISSCR干細(xì)胞騙子”，“加州再生醫(yī)學(xué)研究所iPS細(xì)胞協(xié)會(huì)：ISSCR的克隆傳說”，“人類胚胎干細(xì)胞：最真實(shí)的干細(xì)胞——CIRM卻喪失了真實(shí)性”，“重組狂熱——諾貝爾獎(jiǎng)委身于蓄謀的干細(xì)胞騙局”，“CIRM利益豐厚的RFAs 使符合71號(hào)提案的干細(xì)胞研究本該獲得的合法公共基金無望，卻為違法騙局開綠燈，“iPS細(xì)胞還是人造垃圾”。
    引自詹姆斯·沃森：“即使你能夠?yàn)?5萬癌癥患者進(jìn)行基因測序，這也不能治愈一例患者……”，“我們做的大部分研究都和尋找治療方法無關(guān)……”。

    MEBO國際：我們想了解中國研究員徐榮祥起訴諾獎(jiǎng)委案件的最新進(jìn)展以及詹姆斯·沃森就基因測序無用論的最新陳述。親愛的讀者若感興趣敬請(qǐng)關(guān)注，這畢竟關(guān)乎著再生醫(yī)學(xué)的未來。

人類內(nèi)在的再生能力

    在諾獎(jiǎng)委稱徐的訴訟是無聊之舉之后，徐訴求諾獎(jiǎng)就2012頒獎(jiǎng)詞中的錯(cuò)誤陳述進(jìn)行澄清。該起訴諾獎(jiǎng)委的案件要求對(duì)重要的科學(xué)細(xì)節(jié)進(jìn)行澄清，徐醫(yī)生堅(jiān)信諾獎(jiǎng)委2012諾貝爾獎(jiǎng)?lì)C獎(jiǎng)詞存有錯(cuò)誤陳述。聲明中的錯(cuò)誤不僅對(duì)徐醫(yī)生的科學(xué)造成損害（即內(nèi)在再生潛能），還會(huì)對(duì)全世界人民的健康和安全造成威脅。
    徐要求諾獎(jiǎng)委就人類再生潛能是內(nèi)在的還是人造的進(jìn)行澄清。
 
背景
 
    徐榮祥在應(yīng)用再生復(fù)原科學(xué)中的著作在許多醫(yī)學(xué)領(lǐng)域具有啟示意義如救助嚴(yán)重?zé)齻颊摺⒕哂锌拱┹o助潛能等。隨著最近詹姆斯·沃森就基因測序無用論的發(fā)表，日益增長的干細(xì)胞研究和再生醫(yī)學(xué)需求使該訴訟案備受矚目。

   有關(guān)詹姆斯·沃森評(píng)論和徐醫(yī)生訴訟案的更多消息，請(qǐng)查看： 
UT San Diego - “Watson dings genetics, Irish, fellow Nobelist”: http://bit.ly/Yr5WCB
The Scientist - “Snubbed for a Nobel”: http://bit.ly/X96rjG
Sacramento Bee - “Nobel Assembly Attempts to Downplay Lawsuit with Dr. Rongxiang Xu”:http://bit.ly/10eNuw7
 
更多消息，請(qǐng)登錄 MEBO International Website 或訪問 MEBO International Facebook Page
 
原文鏈接：http://wwwsdrmiorg.blogspot.com/2013/04/nobel-assembly-got-sued-for-awarding.html
 
Nobel Assembly Got Sued for Awarding ISSCR Stem Cell Con Man
 
We’d like to carry the story on Voice of Regenerative Medicine about FIRST LAW SUIT FILED AGAINST NOBEL PRIZE ORGANIZATION CITING DEFAMATION AND UNFAIR COMPETITION PRACTICES. Yamanaka of International Society for Stem Cell Research (ISSCR) put 4 oncogenes into the skin cells of lab rats, then claimed that he had made the safe adult cell alternate of pluripotent human embryonic stem cells (hESCs) by calling it as the induced pluriptoent stem cells (iPS cells) without any scientific evidence for the long-term stable self-renewal of stem cells by the definition of stem cells. The iPS cell of Yamanaka is more accurately known as the induced pluripotent somatic cell or the artificially reprogrammed adult cell. Although scientific term is mandated to be as accurate as possible, Yamanaka’s iPS cell term could not be any more confusing and far away from the truth. Anyone (not short of list) who had done what Yamanaka did before all had the scientific integrity to call what they had done as cancer studies. The only difference is what Yamanaka did was published in the prestigious top scientific Journal “Cell” (How?) that had been quickly endorsed and followed by a group of prestigious scientists of ISSCR that include the “father of stem cell” Jamie Thomson and Rudy Jaenisch and George Daley of Harvard, and had a committee of big names to campaign for Nobel prize for him with sugar-coated hidden political interest or agenda. The iPS abnormal cell of Yamanaka of ISSCR is a serious stem cell scam or fraud committed by someone who has no scientific integrity, misleading the stem cell community and general public to waste the public and taxpayers’ money enormously. The iPS abnormal cells of Yamanaka of ISSCR have created unfair competition practices for normal stem cell research and have stalled human embryonic stem cell research. Please see our blogs about it, such as “CIRM Embezzle State Fund and Resources to Waste on Induced Adult Stem Cell Scam (CIRM iPS Cell Initiative) Against Prop 71 – ISSCR Stem Cell Conman’s Thick Skin”, “CIRM’s iPS Cell Initiative — The Cloning Saga of ISSCR”, “Human Embryonic Stem Cells: The Most Positive Stem Cells — The Positivity CIRM Not Get”, “Frenzy over Reprogramming — Nobel Prize Condescended to Cooked Stem Cell Fraud”, “CIRM Lucrative RFAs Make Prop71 Stem Cell Research Impossible to Get Lawful Public Funds whereas Give Unlawful Frauds the Green Light”, “iPS Cells or Man-Made Junk”.
 
Quote from James Watson: “You could sequence 150,000 people with cancer and it’s not going to cure anyone ---”, “most of the experiments we do are irrelevant (to find a cure) ---”.
MEBO International: We wanted to reach out about the newest developments in Chinese researcher Rongxiang Xu's lawsuit against the Nobel Assembly as well as recent statements by James Watson regarding the ineffectiveness of genetic sequencing. Please take a look to see if this is would interest your readers, as both have relevance for the future of regenerative medicine
 
Human’s Innate Regenerative Ability
 
After Nobel’s assertion that his lawsuit is frivolous, Xu is seeking clarification on misstatements made in awarding the 2012 Nobel Prize. The suit was filed against the Nobel Assembly to clarify essential scientific details that Dr. Xu believed were misstated in their October 2012 Nobel prize announcement. Errors made in the statements not only discredit Dr. Xu's science (which has illustrated innate regenerative potential), but also involve the health and safety of people worldwide.
 
Xu is urging the Assembly to distinguish whether or not the human regenerative potential is innate or must be artificially created.
 
Background
 
Rongxiang Xu’s work in applied regenerative restoration science has implications in many medical fields, including helping severe burn victims and potentially assisting in the fight against cancer. With James Watson’s recent comments regarding the ineffectiveness of genetic sequencing, the growing need for stem cell research and regenerative medicine has made this topic even more relevant.
 
For more background on James Watson’s statements and Dr. Xu’s lawsuit:
 
UT San Diego - “Watson dings genetics, Irish, fellow Nobelist”: http://bit.ly/Yr5WCB
The Scientist - “Snubbed for a Nobel”: http://bit.ly/X96rjG
Sacramento Bee - “Nobel Assembly Attempts to Downplay Lawsuit with Dr. Rongxiang Xu”:http://bit.ly/10eNuw7
 
You can also learn more at the MEBO International Website or visit the MEBO International Facebook Page.